Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 10.00
-0.25 (-2.44%)
Jul 7, 2026, 4:01 PM GMT
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 44.59 million as of July 7, 2026. Its market cap has increased by 69.46% in one year.
Market Cap
44.59M
Enterprise Value
41.84M
Revenue
9.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.00
Market Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 44.59M, a decrease of -55.83%. That is a compound annual growth rate of -13.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 44.59M | 60.77% |
| Dec 31, 2025 | 27.74M | -7.08% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 224.21B |
| GSK plc | 80.29B |
| Haleon | 32.12B |
| Smith & Nephew | 9.56B |
| Shield Therapeutics | 65.71M |
| ECO Animal Health Group | 64.71M |
| Kooth | 58.40M |
| Hemogenyx Pharmaceuticals | 52.36M |